throbber
Scientific
`Research
`Publishing
`
`Materials Sciences and Applications, 2019, 10, 423-431
`Materials Sciences and Applications, 2019, 10, 423 -431
`http://www.scirp.org/journal/msa
`http: / /www.sci rp.org/lournal /msa
`ISSN Online: 2153-1188
`ISSN Online: 2153 -1188
`ISSN Print: 2153-117X
`ISSN Print: 2153 -117X
`
`Viscoelastic Evaluation of Different Hyaluronic
`Viscoelastic Evaluation of Different Hyaluronic
`Acid Based Fillers Using Vibrational Optical
`Acid Based Fillers Using Vibrational Optical
`Coherence Tomography
`Coherence Tomography
`
`Frederick H. Silver1,2*, Ruchit G. Shah3, Nikita Kelkar2,
`Frederick H. Silverl,2*, Ruchit G. Shah3, Nikita Kelkar2,
`Dominick Benedetto4, Dale DeVore5, Justin Cohen6
`Dominick Benedetto4, Dale DeVore5, Justin Cohen6
`
`1Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New
`Jersey, Piscataway, NJ, USA
`2OptoVibronex, LLC, Mt. Bethel, Pa, USA
`3Graduate Program in Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ, USA
`4Center for Advanced Eye Care, Vero Beach, FL, USA
`5DV Consulting, Chelmsford, MA, USA
`6Glasgold Group, Princeton, NJ, USA
`Email: *fhsilver @hotmail.corn
`
`How to cite this paper: Silver, F.H., Shah,
`R.G., Kelkar, N., Benedetto, D., DeVore, D.
`and Cohen, J. (2019) Viscoelastic Evalua-
`tion of Different Hyaluronic Acid Based
`Fillers Using Vibrational Optical Cohe-
`rence Tomography. Materials Sciences and
`Applications, 10, 423-431.
`https://doi.org/10.4236/msa.2019.105031
`
`Received: April 18, 2019
`Accepted: May 24, 2019
`Published: May 27, 2019
`
`Copyright © 2019 by author(s) and
`Scientific Research Publishing Inc.
`This work is licensed under the Creative
`Commons Attribution International
`License (CC BY 4.0).
`http://creativecommons.org/licenses/by/4.0/
`Open Access
`
`Abstract
`Abstract
`Hylauronic acid (HA) is used as a viscoelastic in Ophthalmology during cat-
`aract surgery based on its high viscosity at rest, its ability to shear thin and
`dissipate energy during phacoemulsification. However, these properties of
`HA solutions would make them susceptible to migration when used as der-
`mal filler materials. In this study, we apply a new technique termed vibra-
`tional optical coherence tomography (VOCT) to compare the physical prop-
`erties of different HA solutions and fillers used in facial aesthetics. Results
`presented in this study suggest that HA solutions and HA dermal fillers have
`markedly different physical properties. HA solutions are highly viscoelastic
`with high % viscous losses while fillers tend to have lower viscous energy dis-
`sipation properties. Clinical observations suggest that the high loss fillers are
`injected more superficially in the face where tension and internal and external
`forces are more likely minimized giving tissue of the hands and lips more vo-
`lume and allowing more natural movement. In contrast, the lower loss gels
`that are used to lift tissue, generally have a higher G’, and are injected deeper
`into the face where injection and internal forces are likely to be higher. It is
`concluded that HA filler gel design can be optimized by use of VOCT to eva-
`luate the % viscous energy loss both in vitro and in vivo.
`
`Keywords
`Keywords
`Hyaluronic Acid, Injectable Filler, Dermal Filler, Plastic Surgery, Cosmetic
`
`DOI: 10.4236/msa.2019.105031 May 27, 2019
`DOI: 10.4236/msa.2019.105031 May 27, 2019
`
`423
`423
`
`Materials Sciences and Applications
`Materials Sciences and Applications
`
`Proii2r71lr? Y, Ailerÿarr
`IPR201 9-0 1 600, eral.
`DeVore epo. Ex. 48
`
`ALL 2148
`PROLLENIUM V. ALLERGAN
`IPR2019-01505 et al.
`
`

`

`F. H. Silver et al.
`
`Surgery, Viscoelastic, Mechanical Properties, Facial Surgery, Optical Coherence
`Tomography, Vibrational Optical Coherence Tomography
`
`1. Introduction
`Hyaluronic acid (HA) also known as hyaluronan, is polysaccharide composed of
`repeating β-1-4-linked D-glucuronic acid and β-1-3-linked N-acetyl-D-glucosamine
`disaccharide units [1]. The various names of HA reflect the properties of the
`molecule under various conditions. At neutral pH, HA exists as a polyelectrolyte
`with associated cations, frequently as a sodium salt; therefore, the name sodium
`hyaluronate. The name was later amended to “hyaluronate” in reference to its
`salt form or “hyaluronan,” a term used to encompass all forms of the molecule
`[1].
`HA is found ubiquitously in the ECM of all vertebrate tissues including blood,
`synovial fluid, vitreous body, pericellular matrix, cytoplasm, and nucleus. Its use
`as a viscoelastic in Ophthalmology during cataract surgery is based on the mo-
`lecule’s ability to shear thin and thereby absorb energy during phacoemulsifica-
`tion [2]. This property is a result of the reversible hydrogen bonding that occurs
`between side chains of the molecule [2]. However, to limit its ability to shear
`thin and flow under applied stress requires the formation of covalent crosslinks
`between HA chains.
`Hyaluronic acid (HA) injectable dermal fillers (DFs) have become the most
`popular agents for soft tissue contouring and volumizing. HA fillers are reported
`to be characterized by ideal properties such as biocompatibility, biodegradabili-
`ty, and versatility. These filler properties enable HA DFs to dominate and revo-
`lutionize the filler market with numerous products differing in HA sourcing,
`degree of crosslinking, concentration, hardness, cohesiveness, and consistency.
`The inclusion or lack of inclusion of an anesthetic, indications for use, and lon-
`gevity of correction are other variables examined in designing DFs [3] [4].
`However, there are potential complications that can arise from use of these ma-
`terials [5] [6].
`The rheological and mechanical properties of HA fillers have been reviewed
`recently [4]. HA fillers have been developed that are both viscous solutions and
`solution-gel mixtures containing uncrosslinked and crosslinked macromole-
`cules. HA fillers are crosslinked using a number of different crosslinking agents.
`The HA concentration of fillers ranges from 5.5 to 28 mg/ml, % crosslinking
`from 0 to 20%, shear elastic modulus from 100 to 1800 Pa, and particle size from
`0 to over 1050 micrometers [4]. Observations of the physical properties of HA
`solutions and gels are important parameters that control the behavior of fillers in
`clinical use. However, currently, there are no tests available to study the physical
`properties of fillers both before and after implantation. We have developed a
`new technique termed vibrational optical coherence tomography (VOCT) that
`
`DOI: 10.4236/msa.2019.105031
`
`424
`
`Materials Sciences and Applications
`
`

`

`F. H. Silver et al.
`
`can be used to evaluate HA filler properties both in vitro and in vivo.
`The purpose of this paper is to introduce the use of VOCT to evaluate the
`physical properties of HA fillers before clinical use. VOCT has been used to eva-
`luate the properties of skin and scar tissue in vivo [7]-[14], it can also be used to
`evaluate the mechanical behavior of skin after filler injections. Characterization
`of filler viscoelastic properties is needed to determine the desired clinical out-
`come; how the starting HA filler properties influence the quality of the outcome
`is a question that needs to be answered.
`
`2. Materials and Methods
`VOCT is new technique that measures the resonant frequency and viscous losses
`of solutions of macromolecules and gels. Unlike measurement of solution vis-
`cosity or viscoelasticity using a viscometer, this technique provides measures of
`both cohesive as well as viscous energy dissipation of materials when a mechan-
`ical vibration is applied. This method can be used both in vitro and in vivo
`unlike a viscometer which can only be used in vitro [7]-[14].
`Commercial samples of pure HA with molecular weights of 5 k and 1.8 M
`were obtained from Lifecore Biomedical, LLC. (Chaska, Mn). Samples of dermal
`fillers listed in Table 1 were obtained from Allergan Inc. (Dublin, Ire). A drop
`containing between 0.1 and 0.2 ml of each sample was placed on a glass slide for
`examination. The slide was the placed on a rigid frame that had a hole cut out so
`that the sound was applied to the slide from below. The sample volume did not
`influence the measurement of resonant frequency. Samples were tested at 22˚C
`by applying a sinusoidal sound wave from a speaker placed beneath the sample
`as discussed previously [7]-[14]. The frame, speaker, and glass slide resonant fre-
`quencies were measured in the absence of the samples. Sample weighted displace-
`ments were corrected for any resonant frequencies of the speaker and support
`
`Table 1. HA formulations studied using vibrational optical coherence tomography.
`The % viscous loss is reported at 30 Hz for the HAs studied.
`
`Sample
`
`Conc (mg/ml)
`
`Resonant Freq (Hz) Viscous Loss (%)
`
`Clinical Use
`
`Restylane D
`
`Restylane Lft
`
`Voluma XC
`
`Vollure XC
`
`Restylane L
`
`Juvederm U
`
`Restylane S
`
`HA (5 k)
`
`HA (1.8 M)
`
`20
`
`20
`
`20
`
`17.5
`
`20
`
`24
`
`20
`
`20
`
`20
`
`150
`
`140
`
`150
`
`150
`
`150
`
`140 - 180
`
`180
`
`140
`
`220
`
`27
`
`27
`
`25
`
`35
`
`35
`
`40
`
`40
`
`60
`
`60
`
`md/deep
`
`md/deep
`
`md/deep
`
`sup/md/deep
`
`sup/md/deep
`
`md/sup
`
`sup
`
`N/A
`
`N/A
`
`Note: the standard deviation of resonant frequency measurements is about 6 Hz while that for % viscosity
`measurements is about 10% of the % reported. Abbreviations: sp = superficial, md = mid, N/A = not appli-
`cable, Freq = resonant frequency, Conc = concentration.
`
`DOI: 10.4236/msa.2019.105031
`
`425
`
`Materials Sciences and Applications
`
`

`

`F. H. Silver et al.
`
`materials, or from line voltage variations.
`Transverse forces were applied to the sample by positioning an acoustic
`loudspeaker (Intervox S225RA-40) beneath the sample. A function generator
`(Agilent) was used to drive the speaker with sinusoidal waveforms at varying
`amplitudes and frequencies. The resonant frequency was determined as the fre-
`quency at which the maximum displacement was observed [7]-[14].
`Transverse sample displacement was measured by spectral-domain optical
`coherence tomography (SD-OCT), a non-contact, interferometric technique
`[7]-[14]. The resonant frequency of each sample was initially estimated at a sin-
`gle point by measuring the transverse displacement resulting from sinusoidal
`driving frequencies ranging from 20 Hz to 500 Hz, in steps of 50 Hz. Once the
`region where the maximum displacement was identified, smaller steps of 10 Hz
`were used to more accurately identify the peak frequency and the actual reso-
`nant frequency, fn.
`Measurement of Elastic and Viscous Behaviors
`The elastic and viscous components of the viscoelastic behavior were obtained
`from measurements made from the driving frequency peak as described pre-
`viously [7]-[14]. The elastic component was obtained from the peak height while
`the viscous component was obtained by dividing the change in frequency at the
`half height of the peak (i.e. 3 db down from maximum peak in power spectrum)
`by the driving frequency. This method is known as the half-height bandwidth
`method discussed by Paul Macioce
`(http://www.roush.com/wp-content/uploads/2015/09/Insight.pdf). The viscous
`loss in percent for each sample was tabulated as a function of the applied sound
`frequency.
`
`3. Results
`Weighted displacement versus frequency plots for droplets of pure HA with
`molecular weights 5 k and 1.8 M are shown in Figure 1. Major peaks are shown
`at frequencies of 140 Hz (Mw = 5 k) and 220 Hz (Mw = 1.8 M). The % viscous
`contribution to the viscoelastic behavior is shown in Figure 2. Both pure HA
`samples, independent of molecular weight, have viscous losses that are about
`60% at 30 Hz suggesting that these materials are more viscous than elastic at low
`frequencies. At frequencies above 200 Hz, these HAs have % viscous losses that
`approach 10% and behave almost purely elastically. In the absence of crosslinks,
`HA molecules are highly mobile and do not remain in place when an applied
`force is exerted on their surfaces.
`Weighted displacement measurements versus frequency for representative
`dermal fillers listed in Table 1 are shown in Figure 3 and the % loss behavior for
`typical dermal fillers examined in this study are shown in Figure 4. The
`weighted displacement versus resonant frequency curves for all the filler materials
`exhibit resonant frequencies that center around 150 Hz. The percent loss behaviors
`of the fillers fall into the two groups the group with losses from about 35% to
`
`DOI: 10.4236/msa.2019.105031
`
`426
`
`Materials Sciences and Applications
`
`

`

`F. H. Silver et al.
`F. H. Silver et al.
`
`
`40% at 20 Hz (group A) and those with losses of about 25% (group B) at 20 Hz.
`At high frequencies the % loss decreases to about 5% for all the dermal filler
`samples studied. At high frequencies all fillers behave almost purely elastic. Note
`the gel dermal fillers that are used in cosmetic surgery are more elastic (less
`
`t 1.8M
`-a-5k
`
`
`
`9
`
`8
`
`2
`
`1 0
`
`0
`
`50
`
`100
`
`150
`
`200
`
`250
`
`Frequency (Hz)
`Figure 1. Plot of weighted displacement versus frequency for a drop of purified HA solution with molecular weights of 5 K and
`1.8 M. The major peaks are seen at 140 Hz (Mw = 5 k) and 220 Hz (Mw = 1.5 M) for a drop of solution on a glass slide. Note the
`non-major peaks arise from multiple vibrations associated with within the droplet that occur during energy dissipation.
`
`
`70
`
`60
`
`50
`
`co 40
`oJ
`
`c° 30
`w
`
`20
`
`10
`
`00
`
`50
`
`100
`
`150
`
`200
`
`250
`
`Frequency (Hz)
`Figure 2. % Viscous loss as a function of frequency for a drop of purified HA solutions. Note the % viscous loss of low (5 k) and
`high (1.8 M) molecular weight HA fractions are very high at low frequency (60%) and approach a value of 10% at high frequen-
`cies. At low frequencies HA solutions are viscous liquids that dissipate energy by shear thinning.
`
`DOI: 10.4236/msa.2019.105031
`DOI: 10.4236/msa.2019.105031
`
`
`427
`427
`
`Materials Sciences and Applications
`Materials Sciences and Applications
`
`

`

`
`
`t Vollure XC
`t Voluma XC
`f Restylane
`
`F. H. Silver et al.
`F. H. Silver et al.
`
`200
`
`180
`
`160
`
`. 140
`
`120
`
`aÇi
`
`E8
`
`5 100
`
`aa
`
`)
`rn 80
`
`60
`
`40
`
`20
`
`50
`
`100
`
`150
`
`200
`
`250
`
`Frequency (Hz)
`Figure 3. Typical plot of weighted displacement versus frequency for dermal fillers. Note all dermal fillers had major peaks and
`resonant frequencies at about 150 Hz with several subpeaks being present. Restylane data shown in the figure is for Restylane L.
`
`
`0
`
`0
`
`40
`
`-e- Vollure XC
`f Voluma XC
`t Restylane
`
`30
`
`25
`
`w0
`
`J 20
`
`15
`
`10
`
`0UN
`
`0
`20
`
`40
`
`60
`
`80
`
`100
`200
`120
`
`Frequency (Hz)
`Figure 4. Typical % viscous loss as a function of frequency for dermal fillers. Note the difference between high loss fillers and low
`loss fillers. The high loss group includes Juvederm Ultra, Restylane L, Vollure XC, Restylane Silk. This group had % viscous losses
`in the 35% - 40% range at 20 Hz while the low loss group Voluma XC, Restylane Define, Restylane Lyft and had viscous losses of
`about 25% at 20 Hz. Restylane data shown in the figure is for Restylane L.
`
`
`140
`
`160
`
`180
`
`viscous) at high frequencies than are HA liquid solutions.
`The clinical observations of the uses of the different dermal fillers are shown
`in Table 1. It is observed that group B dermal fillers (Restylane Define, Restylane
`Lyft, Voluma XC), the low loss fillers at low shear rates, are clinically used in the
`mid to deep areas of the skin whereas group A dermal fillers, the high loss fillers
`
`428
`428
`
`Materials Sciences and Applications
`Materials Sciences and Applications
`
`
`DOI: 10.4236/msa.2019.105031
`DOI: 10.4236/msa.2019.105031
`
`
`

`

`F. H. Silver et al.
`
`
`(Juvederm Ultra, Restylane L, Restylane Refine and Restylane Silk, and Vollure
`XC), are generally used more superficially.
`
`4. Discussion
`HA solutions containing polymeric molecules of different molecular weights are
`biocompatible natural materials that are viscoelastic and shear thin at high shear
`rates [3]. While the biocompatibility of these solutions is an important property,
`the viscoelasticity and liquid-like behavior reflected by the high energy loss at
`low frequencies limits their ability to remain in place as filler materials. There-
`fore modifications must be made to solutions of viscoelastics used in Ophthal-
`mology to make these materials function as dermal fillers that do not migrate
`after injection.
`The most important findings reported in this study, suggest that the viscous
`behavior of pure HA solutions is much higher than that obtained with any of the
`dermal filler materials. While pure HA solutions of low and high molecular
`weights exhibit multiple resonant frequencies, it is clear that uncrosslinked,
`non-particulate containing HA solutions independent of molecular weight be-
`have as highly viscoelastic liquids. The high % loss at low frequencies indicates
`that these materials will absorb energy at low shear rates, dissipating energy as
`needed in cataract surgery. Then at high shear rates they act in an elastic fashion
`and can be removed from the eye via their cohesive forces as a bolus of material.
`In contrast they make poor fillers since they will dissipate energy by migrating in
`an irreversible fashion when an external force is applied to tissue.
`In contrast, HA dermal filler materials are required to remain in place after
`injection even after the application of external forces that occur during sleeping
`or other daily activities. The addition of crosslinks and resulting gel particles de-
`creases the shear thinning of HA and reduces the energy losses and viscoelastic-
`ity of the filler materials. HA dermal fillers can be classified into two groups,
`based on the results reported in this paper: the groups are characterized by dif-
`ferences in the viscous losses at low strain rates. The high loss group includes
`Juvederm Ultra, Restylane L, Vollure XC, Restylane Silk. This group had %
`viscous losses in the 35% - 40% range while the low loss group Voluma XC, Res-
`tylane Define, Restylane Lyft and had viscous losses of about 25%.
`Clinically, the high loss “thinner” gel group has been observed to be more ap-
`propriate for superficial indications to remove fine wrinkles and for lip en-
`hancement. Tissue tension due to forces from collagen fibers along Langer’s
`lines and external forces are more likely to be minimized in these regions of the
`face. In contrast, the lower loss “thicker” DF gels that are used to lift tissue, gen-
`erally have a higher G’, and are injected deeper into the face where volume in-
`duced internal forces are likely to be higher. Optimization in the physical prop-
`erties of the injectable dermal fillers evaluated in this study would be difficult to
`achieve without a multifactorial design that considers concentration, particle
`size, and degree of crosslinking in a single study. Differences in these factors
`
`429
`
`Materials Sciences and Applications
`
`
`DOI: 10.4236/msa.2019.105031
`
`
`

`

`F. H. Silver et al.
`
`
`DOI: 10.4236/msa.2019.105031
`
`
`
`
`make analysis of the optimization of filler composition and properties difficult to
`achieve.
`
`5. Conclusions
`HA solutions containing polymeric molecules of different molecular weights are
`biocompatible natural materials that are viscoelastic and shear thin at high shear
`rates. While pure HA solutions of low and high molecular weights exhibit mul-
`tiple resonant frequencies, it is clear that uncrosslinked non-particulate con-
`taining HA solutions independent of molecular weight flow easily under applied
`stress that makes them poor filler materials to use for tissue augmentation. The
`addition of crosslinks and gel particles in HA filler materials decreases the shear
`thinning of HA and reduces the energy losses and viscoelasticity.
`Our results suggest that HA fillers can be categorized into two groups. Clini-
`cally, the high loss group has been observed to be used more superficially in the
`face where tissue tension and internal and external forces are more likely mini-
`mized. In contrast, the lower loss gels that are used to lift tissue, generally have a
`higher G’, and are injected deeper into the face where injection and internal
`forces are likely to be higher. Unlike HA dermal filler gels, HA solutions used in
`cataract surgery exhibit high % viscous losses and are not useful in aesthetic
`surgery due to their tendency to migrate under applied internal and external
`forces. Future work will evaluate the % viscous losses of dermal filler materials
`after injection in vivo.
`
`Conflicts of Interest
`The authors declare no conflicts of interest regarding the publication of this paper.
`
`References
`[1] Dicker, K.T., Gurski, L.A., Pradhan-Bhat, S., Witt, R.L., Farach-Carson, M.C. and
`Jia, X. (2014) Hyaluronan: A Simple Polysaccharide with Diverse Biological Func-
`tions. Acta Biomaterialia, 10, 1558-1570.
`https://doi.org/10.1016/j.actbio.2013.12.019
`[2] Silver, F.H. and Benedetto, D. (1996) Polysaccharides Used in Ophthalmology. In:
`Dumitriu, S., Ed., Polysaccharides Used in Medicinal Applications, Marcel Dekker
`Inc., New York, 689-703.
`[3] Fallacara, A., Manfredini, S., Durini, E. and Vertuani, S. (2017) Hyaluronic Acid
`Fillers in Soft Tissue Regeneration. Facial Plastics Surgery, 33, 87-96.
`https://doi.org/10.1055/s-0036-1597685
`[4] Greene, J.J. and Sidle, D.M. (2015) The Hyaluronic Acid Fillers Current Under-
`standing of the Tissue Device Interface. Facial Plastic Surgery Clinics of North
`America, 23, 423-432. https://doi.org/10.1016/j.fsc.2015.07.002
`[5] Urdiales-Gálvez, F., Escoda Delgado, N., Figueiredo, V., Lajo-Plaza, J.V., Mira, M.,
`Mar Mira, Ortíz-Martí, F., del Rio-Reyes, R., Romero-Á lvarez, N., Ruiz del Cueto,
`S., Martía A. Segurado, M.A. and Villanueva Rebenaque, C. (2017) Preventing the
`Complications Associated with the Use of Dermal Fillers in Facial Aesthetic Proce-
`dures: An Expert Group Consensus Report. Aesthetic Plastic Surgery, 41, 667-677.
`
`430
`
`Materials Sciences and Applications
`
`

`

`F. H. Silver et al.
`
`
`https://doi.org/10.1007/s00266-017-0798-y
`[6] Vedamurthy, M. (2018) Beware What You Inject: Complications of Injec-
`tables-Dermal Fillers. Journal of Cutaneous and Aesthetic Surgery, 11, 60-66.
`https://doi.org/10.4103/JCAS.JCAS_68_18
`[7] Shah, R., DeVore, D. and Pierce, M.G. (2016) Morphomechanics of Dermis: A Me-
`thod for Non-Destructive Testing and Collagenous Tissues. Skin Research and
`Technology, 23.
`[8] Shah, R., Pierce, M.C. and Silver, F.H. (2017) A Method for Non-Destructive Me-
`chanical Testing of Tissues and Implants. Journal of Biomedical Materials Research
`Part A, 105, 5-22. https://doi.org/10.1002/jbm.a.35859
`[9] Silver, F.H. and Silver, L.L. (2017) Non-Invasive Viscoelastic Behavior of Human
`Skin and Decellularized Dermis Using Vibrational OCT. Dermatology Clinics &
`Research, 3, 174-179.
`[10] Shah, R.G., DeVore, D. and Silver, F.H. (2018). Biomechanical Analysis of Decellu-
`larized Dermis and Skin: Initial in Vivo Observations Using OCT and Vibrational
`Analysis. JJournal of Biomedical Materials Research Part A, 106.
`https://doi.org/10.1002/jbm.a.36344
`[11] Silver, F.H., DeVore, D. and Shah, R. (2017) Biochemical, Biophysical and Mechan-
`ical Characterization of Decellularized Dermal Implants. Material Sciences and Ap-
`plications, 8, 873-888. https://doi.org/10.4236/msa.2017.812064
`[12] Silver, F.H. and Shah, R.G. (2018) Mechanical Spectroscopy and Imaging of Skin
`Components in Vivo: Assignment of the Observed Moduli. Skin Research and
`Technology, 25. https://doi.org/10.1111/srt.12594
`[13] Silver, F.H. and Silver, L.L. (2018) Use of Vibrational Optical Coherence Tomogra-
`phy in Dermatology. Archives of Dermatology and Skin Care, 1, 3-8.
`[14] Silver, F.H., Shah, R.G., Benedetto, D., Dulur, A. and Kirn, T. (2019) Virtual Biopsy
`and Physical Characterization of Tissues, Biofilms, Implants and Viscoelastic Liq-
`uids Using Vibrational Optical Coherence Tomography. World Journal Mechanics,
`9, 1-6. https://doi.org/10.4236/wjm.2019.91001
`
`
`
`
`
`DOI: 10.4236/msa.2019.105031
`
`
`431
`
`Materials Sciences and Applications
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket